Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer | Citedby Results | Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer

Clin Cancer Res (2023) 29 (7): 1232–1242.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Targeting CDCP1 boost CD8+ T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway

Hua Huang
Yuwen Pan
Qiuwen Mai
Chunyu Zhang
Qiqiao Du
Yuandong Liao
Shuhang Qin
Yili Chen
Jiaming Huang
Jie Li
Tianyu Liu
Qiaojian Zou
Yijia Zhou
Li Yuan
Wei Wang
Yanchun Liang
Chao Yun Pan
Junxiu Liu
Shuzhong Yao

Journal for ImmunoTherapy of Cancer (2024) 12 (10): e009416.

Developing and Verifying an Effective Diagnostic Model Linked to Immune Infiltration in Stanford Type A Aortic Dissection

Xiaoyan Huang
Guoan Zhang
Yangmeng Feng
Xiangrong Zhao
Yaping Li
Fuqiang Liu
Yihan Dong
Jingying Sun
Cuixiang Xu

Frontiers in Bioscience-Landmark (2024) 29 (9)

The Role of Antibody-Drug Conjugates in Urothelial Cancer: A Review of Recent Advances in the Treatment of Locally Advanced and Metastatic Urothelial Cancer

Evangelia Vlachou
Burles Avner Johnson
Jean Hoffman-Censits

Clinical Medicine Insights: Oncology (2024) 18

Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future

William Echavidre
Daniel Fagret
Marc Faraggi
Vincent Picco
Christopher Montemagno

Cancers (2023) 15 (19): 4839.